NCT04150172View on ClinicalTrials.gov

To Evaluate Pharmacokinetics and Safety of Two Different Formulation of Rebamipide in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 22, 2019

Primary Completion Date

May 1, 2019

Study Completion Date

May 10, 2019

Conditions
Healthy Volunteers
Interventions
DRUG

Rebamipide SR 150mg

Test drug

DRUG

Rebamipide IR 100mg

Reference Drug

Trial Locations (1)

13496

CHA Bundang Medical Center, CHA University, Seongnam-si

Sponsors
All Listed Sponsors
lead

Korea Otsuka Pharmaceutical Co., Ltd.

INDUSTRY